Skip to main content
Top
Published in: Pain and Therapy 5/2023

Open Access 09-08-2023 | Opioids | ORIGINAL RESEARCH

Preoperative Versus Perioperative Risk Factors for Delayed Pain and Opioid Cessation After Total Joint Arthroplasty: A Prospective Cohort Study

Authors: Jennifer M. Hah, Julien D. Veron Vialard, Bradley Efron, Sean C. Mackey, Ian R. Carroll, Derek F. Amanatullah, Balasubramanian Narasimhan, Tina Hernandez-Boussard

Published in: Pain and Therapy | Issue 5/2023

Login to get access

Abstract

Introduction

The evolution of pre- versus postoperative risk factors remains unknown in the development of persistent postoperative pain and opioid use. We identified preoperative versus comprehensive perioperative models of delayed pain and opioid cessation after total joint arthroplasty including time-varying postoperative changes in emotional distress. We hypothesized that time-varying longitudinal measures of postoperative psychological distress, as well as pre- and postoperative use of opioids would be the most significant risk factors for both outcomes.

Methods

A prospective cohort of 188 patients undergoing total hip or knee arthroplasty at Stanford Hospital completed baseline pain, opioid use, and emotional distress assessments. After surgery, a modified Brief Pain Inventory was assessed daily for 3 months, weekly thereafter up to 6 months, and monthly thereafter up to 1 year. Emotional distress and pain catastrophizing were assessed weekly to 6 months, then monthly thereafter. Stepwise multivariate time-varying Cox regression modeled preoperative variables alone, followed by all perioperative variables (before and after surgery) with time to postoperative opioid and pain cessation.

Results

The median time to opioid and pain cessation was 54 and 152 days, respectively. Preoperative total daily oral morphine equivalent use (hazard ratio-HR 0.97; 95% confidence interval-CI 0.96–0.98) was significantly associated with delayed postoperative opioid cessation in the perioperative model. In contrast, time-varying postoperative factors: elevated PROMIS (Patient-Reported Outcomes Measurement Information System) depression scores (HR 0.92; 95% CI 0.87–0.98), and higher Pain Catastrophizing Scale scores (HR 0.85; 95% CI 0.75–0.97) were independently associated with delayed postoperative pain resolution in the perioperative model.

Conclusions

These findings highlight preoperative opioid use as a key determinant of delayed postoperative opioid cessation, while postoperative elevations in depressive symptoms and pain catastrophizing are associated with persistent pain after total joint arthroplasty providing the rationale for continued risk stratification before and after surgery to identify patients at highest risk for these distinct outcomes. Interventions targeting these perioperative risk factors may prevent prolonged postoperative pain and opioid use.
Appendix
Available only for authorised users
Literature
1.
go back to reference Howard R, Brown CS, Lai YL, et al. Postoperative opioid prescribing and new persistent opioid use: the risk of excessive prescribing. Ann Surg. 2023;277(6):e1225–31.CrossRef Howard R, Brown CS, Lai YL, et al. Postoperative opioid prescribing and new persistent opioid use: the risk of excessive prescribing. Ann Surg. 2023;277(6):e1225–31.CrossRef
3.
go back to reference Lawal OD, Gold J, Murthy A, et al. Rate and risk factors associated with prolonged opioid use after surgery: a systematic review and meta-analysis. JAMA Netw Open. 2020;3(6): e207367.PubMedPubMedCentralCrossRef Lawal OD, Gold J, Murthy A, et al. Rate and risk factors associated with prolonged opioid use after surgery: a systematic review and meta-analysis. JAMA Netw Open. 2020;3(6): e207367.PubMedPubMedCentralCrossRef
4.
go back to reference Tay HP, Wang X, Narayan SW, Penm J, Patanwala AE. Persistent postoperative opioid use after total hip or knee arthroplasty: a systematic review and meta-analysis. Am J Health Syst Pharm. 2022;79(3):147–64.PubMedCrossRef Tay HP, Wang X, Narayan SW, Penm J, Patanwala AE. Persistent postoperative opioid use after total hip or knee arthroplasty: a systematic review and meta-analysis. Am J Health Syst Pharm. 2022;79(3):147–64.PubMedCrossRef
5.
go back to reference Hannon CP, Fillingham YA, Nam D, et al. The efficacy and safety of opioids in total joint arthroplasty: systematic review and direct meta-analysis. J Arthroplasty. 2020;35(10):2759-71.e13.PubMedCrossRef Hannon CP, Fillingham YA, Nam D, et al. The efficacy and safety of opioids in total joint arthroplasty: systematic review and direct meta-analysis. J Arthroplasty. 2020;35(10):2759-71.e13.PubMedCrossRef
6.
go back to reference Wylde V, Hewlett S, Learmonth ID, Dieppe P. Persistent pain after joint replacement: prevalence, sensory qualities, and postoperative determinants. Pain. 2011;152(3):566–72.PubMedCrossRef Wylde V, Hewlett S, Learmonth ID, Dieppe P. Persistent pain after joint replacement: prevalence, sensory qualities, and postoperative determinants. Pain. 2011;152(3):566–72.PubMedCrossRef
7.
go back to reference Hah JM, Hilmoe H, Schmidt P, et al. Preoperative factors associated with remote postoperative pain resolution and opioid cessation in a mixed surgical cohort: post hoc analysis of a perioperative gabapentin trial. J Pain Res. 2020;13:2959–70.PubMedPubMedCentralCrossRef Hah JM, Hilmoe H, Schmidt P, et al. Preoperative factors associated with remote postoperative pain resolution and opioid cessation in a mixed surgical cohort: post hoc analysis of a perioperative gabapentin trial. J Pain Res. 2020;13:2959–70.PubMedPubMedCentralCrossRef
8.
go back to reference Hah JM, Trafton JA, Narasimhan B, et al. Efficacy of motivational-interviewing and guided opioid tapering support for patients undergoing orthopedic surgery (MI-Opioid Taper): a prospective, assessor-blind, randomized controlled pilot trial. EClinicalMedicine. 2020;28: 100596.PubMedPubMedCentralCrossRef Hah JM, Trafton JA, Narasimhan B, et al. Efficacy of motivational-interviewing and guided opioid tapering support for patients undergoing orthopedic surgery (MI-Opioid Taper): a prospective, assessor-blind, randomized controlled pilot trial. EClinicalMedicine. 2020;28: 100596.PubMedPubMedCentralCrossRef
9.
go back to reference Jorgensen CC, Petersen M, Kehlet H, Aasvang EK. Analgesic consumption trajectories in 8975 patients 1 year after fast-track total hip or knee arthroplasty. Eur J Pain. 2018;22:1428–38.CrossRef Jorgensen CC, Petersen M, Kehlet H, Aasvang EK. Analgesic consumption trajectories in 8975 patients 1 year after fast-track total hip or knee arthroplasty. Eur J Pain. 2018;22:1428–38.CrossRef
10.
go back to reference Rajamaki TJ, Moilanen T, Puolakka PA, Hietaharju A, Jamsen E. Is the preoperative use of antidepressants and benzodiazepines associated with opioid and other analgesic use after hip and knee arthroplasty? Clin Orthop Relat Res. 2021;479(10):2268–80.PubMedPubMedCentralCrossRef Rajamaki TJ, Moilanen T, Puolakka PA, Hietaharju A, Jamsen E. Is the preoperative use of antidepressants and benzodiazepines associated with opioid and other analgesic use after hip and knee arthroplasty? Clin Orthop Relat Res. 2021;479(10):2268–80.PubMedPubMedCentralCrossRef
11.
go back to reference Ashoorion V, Sadeghirad B, Wang L, et al. Predictors of persistent post-surgical pain following total knee arthroplasty: a systematic review and meta-analysis of observational studies. Pain Med. 2023;24(4):369–81.PubMedCrossRef Ashoorion V, Sadeghirad B, Wang L, et al. Predictors of persistent post-surgical pain following total knee arthroplasty: a systematic review and meta-analysis of observational studies. Pain Med. 2023;24(4):369–81.PubMedCrossRef
12.
go back to reference Wunsch H, Hill AD, Bethell J, et al. Surgeon postoperative opioid prescribing intensity and risk of persistent opioid use among opioid-naive adult patients: a population-based cohort study. Ann Surg. 2021;277:767–74.CrossRef Wunsch H, Hill AD, Bethell J, et al. Surgeon postoperative opioid prescribing intensity and risk of persistent opioid use among opioid-naive adult patients: a population-based cohort study. Ann Surg. 2021;277:767–74.CrossRef
13.
go back to reference Chan B, Ward S, Abdallah FW, et al. Opioid prescribing and utilization patterns in patients having elective hip and knee arthroplasty: association between prescription patterns and opioid consumption. Can J Anaesth. 2021;69:953–62.PubMedCrossRef Chan B, Ward S, Abdallah FW, et al. Opioid prescribing and utilization patterns in patients having elective hip and knee arthroplasty: association between prescription patterns and opioid consumption. Can J Anaesth. 2021;69:953–62.PubMedCrossRef
14.
go back to reference Hah JM, Cramer E, Hilmoe H, et al. Factors associated with acute pain estimation, postoperative pain resolution, opioid cessation, and recovery: secondary analysis of a randomized clinical trial. JAMA Netw Open. 2019;2(3): e190168.PubMedPubMedCentralCrossRef Hah JM, Cramer E, Hilmoe H, et al. Factors associated with acute pain estimation, postoperative pain resolution, opioid cessation, and recovery: secondary analysis of a randomized clinical trial. JAMA Netw Open. 2019;2(3): e190168.PubMedPubMedCentralCrossRef
15.
go back to reference Hah JM, Nwaneshiudu CA, Cramer EM, Carroll IR, Curtin CM. Acute pain predictors of remote postoperative pain resolution after hand surgery. Pain Ther. 2021;10(2):1105–19.PubMedPubMedCentralCrossRef Hah JM, Nwaneshiudu CA, Cramer EM, Carroll IR, Curtin CM. Acute pain predictors of remote postoperative pain resolution after hand surgery. Pain Ther. 2021;10(2):1105–19.PubMedPubMedCentralCrossRef
16.
go back to reference Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71.PubMedCrossRef Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71.PubMedCrossRef
17.
go back to reference Keller S, Bann CM, Dodd SL, et al. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain. 2004;20(5):309–18.PubMedCrossRef Keller S, Bann CM, Dodd SL, et al. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain. 2004;20(5):309–18.PubMedCrossRef
18.
go back to reference Pilkonis PA, Choi SW, Reise SP, et al. Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS(R)): depression, anxiety, and anger. Assessment. 2011;18(3):263–83.PubMedPubMedCentralCrossRef Pilkonis PA, Choi SW, Reise SP, et al. Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS(R)): depression, anxiety, and anger. Assessment. 2011;18(3):263–83.PubMedPubMedCentralCrossRef
19.
go back to reference Pilkonis PA, Yu L, Dodds NE, et al. Validation of the depression item bank from the Patient-Reported Outcomes Measurement Information System (PROMIS) in a three-month observational study. J Psychiatr Res. 2014;56:112–9.PubMedPubMedCentralCrossRef Pilkonis PA, Yu L, Dodds NE, et al. Validation of the depression item bank from the Patient-Reported Outcomes Measurement Information System (PROMIS) in a three-month observational study. J Psychiatr Res. 2014;56:112–9.PubMedPubMedCentralCrossRef
20.
go back to reference Schalet BD, Pilkonis PA, Yu L, et al. Clinical validity of PROMIS depression, anxiety, and anger across diverse clinical samples. J Clin Epidemiol. 2016;73:119–27.PubMedPubMedCentralCrossRef Schalet BD, Pilkonis PA, Yu L, et al. Clinical validity of PROMIS depression, anxiety, and anger across diverse clinical samples. J Clin Epidemiol. 2016;73:119–27.PubMedPubMedCentralCrossRef
21.
go back to reference Wang YP, Gorenstein C. Psychometric properties of the Beck Depression Inventory-II: a comprehensive review. Braz J Psychiatry. 2013;35(4):416–31.PubMedCrossRef Wang YP, Gorenstein C. Psychometric properties of the Beck Depression Inventory-II: a comprehensive review. Braz J Psychiatry. 2013;35(4):416–31.PubMedCrossRef
22.
go back to reference Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988;54(6):1063–70.PubMedCrossRef Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988;54(6):1063–70.PubMedCrossRef
23.
go back to reference Starr CJ, Houle TT, Coghill RC. Psychological and sensory predictors of experimental thermal pain: a multifactorial model. J Pain. 2010;11(12):1394–402.PubMedPubMedCentralCrossRef Starr CJ, Houle TT, Coghill RC. Psychological and sensory predictors of experimental thermal pain: a multifactorial model. J Pain. 2010;11(12):1394–402.PubMedPubMedCentralCrossRef
24.
go back to reference Ruiz-Aranda D, Salguero JM, Fernandez-Berrocal P. Emotional intelligence and acute pain: the mediating effect of negative affect. J Pain. 2011;12(11):1190–6.PubMedCrossRef Ruiz-Aranda D, Salguero JM, Fernandez-Berrocal P. Emotional intelligence and acute pain: the mediating effect of negative affect. J Pain. 2011;12(11):1190–6.PubMedCrossRef
25.
go back to reference Ostir GV, Smith PM, Smith D, Ottenbacher KJ. Reliability of the positive and negative affect schedule (PANAS) in medical rehabilitation. Clin Rehabil. 2005;19(7):767–9.PubMedCrossRef Ostir GV, Smith PM, Smith D, Ottenbacher KJ. Reliability of the positive and negative affect schedule (PANAS) in medical rehabilitation. Clin Rehabil. 2005;19(7):767–9.PubMedCrossRef
26.
27.
go back to reference Leue A, Lange S. Reliability generalization: an examination of the Positive Affect and Negative Affect Schedule. Assessment. 2011;18(4):487–501.PubMedCrossRef Leue A, Lange S. Reliability generalization: an examination of the Positive Affect and Negative Affect Schedule. Assessment. 2011;18(4):487–501.PubMedCrossRef
28.
go back to reference Crawford JR, Henry JD. The positive and negative affect schedule (PANAS): construct validity, measurement properties and normative data in a large non-clinical sample. Br J Clin Psychol. 2004;43(Pt 3):245–65.PubMedCrossRef Crawford JR, Henry JD. The positive and negative affect schedule (PANAS): construct validity, measurement properties and normative data in a large non-clinical sample. Br J Clin Psychol. 2004;43(Pt 3):245–65.PubMedCrossRef
29.
go back to reference Sullivan MJ, Bishop SR, Pivik J. The pain catastrophizing scale: development and validation. Psychol Assess. 1995;7(4):524.CrossRef Sullivan MJ, Bishop SR, Pivik J. The pain catastrophizing scale: development and validation. Psychol Assess. 1995;7(4):524.CrossRef
30.
go back to reference Wheeler CHB, Williams ACC, Morley SJ. Meta-analysis of the psychometric properties of the Pain Catastrophizing Scale and associations with participant characteristics. Pain. 2019;160(9):1946–53.PubMedCrossRef Wheeler CHB, Williams ACC, Morley SJ. Meta-analysis of the psychometric properties of the Pain Catastrophizing Scale and associations with participant characteristics. Pain. 2019;160(9):1946–53.PubMedCrossRef
31.
go back to reference Carroll I, Barelka P, Wang CK, et al. A pilot cohort study of the determinants of longitudinal opioid use after surgery. Anesth Analg. 2012;115(3):694–702.PubMedCrossRef Carroll I, Barelka P, Wang CK, et al. A pilot cohort study of the determinants of longitudinal opioid use after surgery. Anesth Analg. 2012;115(3):694–702.PubMedCrossRef
32.
go back to reference Pourhoseingholi MA, Hajizadeh E, Moghimi Dehkordi B, et al. Comparing Cox regression and parametric models for survival of patients with gastric carcinoma. Asian Pac J Cancer Prev. 2007;8(3):412–6.PubMed Pourhoseingholi MA, Hajizadeh E, Moghimi Dehkordi B, et al. Comparing Cox regression and parametric models for survival of patients with gastric carcinoma. Asian Pac J Cancer Prev. 2007;8(3):412–6.PubMed
33.
go back to reference Profillidis VA, Botzoris GN. Modeling of transport demand: analyzing, calculating and forecasting transport demand. Amsterdam: Elsevier; 2019. p. 472 (xxvi). Profillidis VA, Botzoris GN. Modeling of transport demand: analyzing, calculating and forecasting transport demand. Amsterdam: Elsevier; 2019. p. 472 (xxvi).
34.
go back to reference Giordano NA, Highland KB, Nghiem V, Scott-Richardson M, Kent M. Predictors of continued opioid use 6 months after total joint arthroplasty: a multi-site study. Arch Orthop Trauma Surg. 2021;142:4033–39.PubMedCrossRef Giordano NA, Highland KB, Nghiem V, Scott-Richardson M, Kent M. Predictors of continued opioid use 6 months after total joint arthroplasty: a multi-site study. Arch Orthop Trauma Surg. 2021;142:4033–39.PubMedCrossRef
35.
go back to reference Kunkel ST, Gregory JJ, Sabatino MJ, et al. Does preoperative opioid consumption increase the risk of chronic postoperative opioid use after total joint arthroplasty? Arthroplast Today. 2021;10:46–50.PubMedPubMedCentralCrossRef Kunkel ST, Gregory JJ, Sabatino MJ, et al. Does preoperative opioid consumption increase the risk of chronic postoperative opioid use after total joint arthroplasty? Arthroplast Today. 2021;10:46–50.PubMedPubMedCentralCrossRef
36.
go back to reference Sheth DS, Ho N, Pio JR, et al. Prolonged opioid use after primary total knee and total hip arthroplasty: prospective evaluation of risk factors and psychological profile for depression, pain catastrophizing, and aberrant drug-related behavior. J Arthroplasty. 2020;35(12):3535–44.PubMedCrossRef Sheth DS, Ho N, Pio JR, et al. Prolonged opioid use after primary total knee and total hip arthroplasty: prospective evaluation of risk factors and psychological profile for depression, pain catastrophizing, and aberrant drug-related behavior. J Arthroplasty. 2020;35(12):3535–44.PubMedCrossRef
37.
go back to reference Pryymachenko Y, Wilson RA, Abbott JH, Dowsey MM, Choong PFM. Risk factors for chronic opioid use following hip and knee arthroplasty: evidence from New Zealand population data. J Arthroplasty. 2020;35(11):3099-107.e14.PubMedCrossRef Pryymachenko Y, Wilson RA, Abbott JH, Dowsey MM, Choong PFM. Risk factors for chronic opioid use following hip and knee arthroplasty: evidence from New Zealand population data. J Arthroplasty. 2020;35(11):3099-107.e14.PubMedCrossRef
38.
go back to reference Gabriel RA, Harjai B, Prasad RS, et al. Machine learning approach to predicting persistent opioid use following lower extremity joint arthroplasty. Reg Anesth Pain Med. 2022;47(5):313–9.PubMedPubMedCentralCrossRef Gabriel RA, Harjai B, Prasad RS, et al. Machine learning approach to predicting persistent opioid use following lower extremity joint arthroplasty. Reg Anesth Pain Med. 2022;47(5):313–9.PubMedPubMedCentralCrossRef
39.
go back to reference Malahias MA, Loucas R, Loucas M, et al. Preoperative opioid use is associated with higher revision rates in total joint arthroplasty: a systematic review. J Arthroplasty. 2021;36(11):3814–21.PubMedCrossRef Malahias MA, Loucas R, Loucas M, et al. Preoperative opioid use is associated with higher revision rates in total joint arthroplasty: a systematic review. J Arthroplasty. 2021;36(11):3814–21.PubMedCrossRef
40.
go back to reference Simonsson J, Bulow E, Svensson Malchau K, et al. Worse patient-reported outcomes and higher risk of reoperation and adverse events after total hip replacement in patients with opioid use in the year before surgery: a Swedish register-based study on 80,483 patients. Acta Orthop. 2022;93:190–7.PubMedPubMedCentralCrossRef Simonsson J, Bulow E, Svensson Malchau K, et al. Worse patient-reported outcomes and higher risk of reoperation and adverse events after total hip replacement in patients with opioid use in the year before surgery: a Swedish register-based study on 80,483 patients. Acta Orthop. 2022;93:190–7.PubMedPubMedCentralCrossRef
41.
go back to reference Terhune EB, Hannon CP, Burnett RA, Della Valle CJ. Preoperative opioids and the dose-dependent effect on outcomes after total hip arthroplasty. J Arthroplasty. 2021. Terhune EB, Hannon CP, Burnett RA, Della Valle CJ. Preoperative opioids and the dose-dependent effect on outcomes after total hip arthroplasty. J Arthroplasty. 2021.
42.
go back to reference Awadalla SS, Winslow V, Avidan MS, Haroutounian S, Kannampallil TG. Effect of acute postsurgical pain trajectories on 30-day and 1-year pain. PLoS ONE. 2022;17(6): e0269455.PubMedPubMedCentralCrossRef Awadalla SS, Winslow V, Avidan MS, Haroutounian S, Kannampallil TG. Effect of acute postsurgical pain trajectories on 30-day and 1-year pain. PLoS ONE. 2022;17(6): e0269455.PubMedPubMedCentralCrossRef
43.
44.
go back to reference Soffin EM, Wilson LA, Liu J, Poeran J, Memtsoudis SG. Association between sex and perioperative opioid prescribing for total joint arthroplasty: a retrospective population-based study. Br J Anaesth. 2021;126(6):1217–25.PubMedCrossRef Soffin EM, Wilson LA, Liu J, Poeran J, Memtsoudis SG. Association between sex and perioperative opioid prescribing for total joint arthroplasty: a retrospective population-based study. Br J Anaesth. 2021;126(6):1217–25.PubMedCrossRef
45.
go back to reference Fillingham YA, Hanson TM, Leinweber KA, Lucas AP, Jevsevar DS. Generalized anxiety disorder: a modifiable risk factor for pain catastrophizing after total joint arthroplasty. J Arthroplasty. 2021;36(7S):S179–83.PubMedCrossRef Fillingham YA, Hanson TM, Leinweber KA, Lucas AP, Jevsevar DS. Generalized anxiety disorder: a modifiable risk factor for pain catastrophizing after total joint arthroplasty. J Arthroplasty. 2021;36(7S):S179–83.PubMedCrossRef
46.
go back to reference Xu J, Twiggs J, Parker D, Negus J. The association between anxiety, depression, and locus of control with patient outcomes following total knee arthroplasty. J Arthroplasty. 2020;35(3):720–4.PubMedCrossRef Xu J, Twiggs J, Parker D, Negus J. The association between anxiety, depression, and locus of control with patient outcomes following total knee arthroplasty. J Arthroplasty. 2020;35(3):720–4.PubMedCrossRef
47.
go back to reference Hasegawa M, Tone S, Naito Y, Sudo A. Preoperative pain catastrophizing affects pain outcome after total knee arthroplasty. J Orthop Sci. 2021;27:1096–99.PubMedCrossRef Hasegawa M, Tone S, Naito Y, Sudo A. Preoperative pain catastrophizing affects pain outcome after total knee arthroplasty. J Orthop Sci. 2021;27:1096–99.PubMedCrossRef
48.
go back to reference Sabo MT, Roy M. Surgeon identification of pain catastrophizing versus the Pain Catastrophizing Scale in orthopedic patients after routine surgical consultation. Can J Surg. 2019;62(4):265–9.PubMedPubMedCentralCrossRef Sabo MT, Roy M. Surgeon identification of pain catastrophizing versus the Pain Catastrophizing Scale in orthopedic patients after routine surgical consultation. Can J Surg. 2019;62(4):265–9.PubMedPubMedCentralCrossRef
49.
go back to reference Giordano NA, Kane A, Jannace KC, et al. Discrete and dynamic postoperative pain catastrophizing trajectories across 6 months: a prospective observational study. Arch Phys Med Rehabil. 2020;101(10):1754–62.PubMedCrossRef Giordano NA, Kane A, Jannace KC, et al. Discrete and dynamic postoperative pain catastrophizing trajectories across 6 months: a prospective observational study. Arch Phys Med Rehabil. 2020;101(10):1754–62.PubMedCrossRef
50.
go back to reference Speed TJ, Jung Mun C, Smith MT, et al. Temporal association of pain catastrophizing and pain severity across the perioperative period: a cross-lagged panel analysis after total knee arthroplasty. Pain Med. 2021;22(8):1727–34.PubMedPubMedCentralCrossRef Speed TJ, Jung Mun C, Smith MT, et al. Temporal association of pain catastrophizing and pain severity across the perioperative period: a cross-lagged panel analysis after total knee arthroplasty. Pain Med. 2021;22(8):1727–34.PubMedPubMedCentralCrossRef
51.
go back to reference Kroenke K, Stump TE, Chen CX, et al. Minimally important differences and severity thresholds are estimated for the PROMIS depression scales from three randomized clinical trials. J Affect Disord. 2020;266:100–8.PubMedPubMedCentralCrossRef Kroenke K, Stump TE, Chen CX, et al. Minimally important differences and severity thresholds are estimated for the PROMIS depression scales from three randomized clinical trials. J Affect Disord. 2020;266:100–8.PubMedPubMedCentralCrossRef
52.
go back to reference Beaupre LA, Kang SH, Jhangri GS, Boettcher T, Jones CA. Impact of depressive symptomology on pain and function during recovery after total joint arthroplasty. South Med J. 2021;114(8):450–7.PubMedCrossRef Beaupre LA, Kang SH, Jhangri GS, Boettcher T, Jones CA. Impact of depressive symptomology on pain and function during recovery after total joint arthroplasty. South Med J. 2021;114(8):450–7.PubMedCrossRef
53.
go back to reference Niederstrasser NG, Cook S. Investigating the true effect of psychological variables measured prior to arthroplastic surgery on postsurgical outcomes: a P-curve analysis. J Pain. 2021;22(4):400–14.PubMedCrossRef Niederstrasser NG, Cook S. Investigating the true effect of psychological variables measured prior to arthroplastic surgery on postsurgical outcomes: a P-curve analysis. J Pain. 2021;22(4):400–14.PubMedCrossRef
54.
go back to reference Althaus A, Arranz Becker O, Neugebauer E. Distinguishing between pain intensity and pain resolution: using acute post-surgical pain trajectories to predict chronic post-surgical pain. Eur J Pain. 2014;18(4):513–21.PubMedCrossRef Althaus A, Arranz Becker O, Neugebauer E. Distinguishing between pain intensity and pain resolution: using acute post-surgical pain trajectories to predict chronic post-surgical pain. Eur J Pain. 2014;18(4):513–21.PubMedCrossRef
55.
go back to reference Riddle DL, Perera RA, Nay WT, Dumenci L. What is the relationship between depressive symptoms and pain during functional tasks in persons undergoing TKA? A 6-year perioperative cohort study. Clin Orthop Relat Res. 2015;473(11):3527–34.PubMedPubMedCentralCrossRef Riddle DL, Perera RA, Nay WT, Dumenci L. What is the relationship between depressive symptoms and pain during functional tasks in persons undergoing TKA? A 6-year perioperative cohort study. Clin Orthop Relat Res. 2015;473(11):3527–34.PubMedPubMedCentralCrossRef
57.
go back to reference Harrell JFE. Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis. Cham: Springer International Publishing; 2015. (Imprint: Springer).CrossRef Harrell JFE. Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis. Cham: Springer International Publishing; 2015. (Imprint: Springer).CrossRef
Metadata
Title
Preoperative Versus Perioperative Risk Factors for Delayed Pain and Opioid Cessation After Total Joint Arthroplasty: A Prospective Cohort Study
Authors
Jennifer M. Hah
Julien D. Veron Vialard
Bradley Efron
Sean C. Mackey
Ian R. Carroll
Derek F. Amanatullah
Balasubramanian Narasimhan
Tina Hernandez-Boussard
Publication date
09-08-2023
Publisher
Springer Healthcare
Published in
Pain and Therapy / Issue 5/2023
Print ISSN: 2193-8237
Electronic ISSN: 2193-651X
DOI
https://doi.org/10.1007/s40122-023-00543-9

Other articles of this Issue 5/2023

Pain and Therapy 5/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine